Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -14.49% is 80% above its 5-year average of -70.72%, near the high end of its 5-year range (-292.01%–-0.84%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.22% below its 12-month average of -13.15%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -14.49%.
RETURN ON EQUITY (ROE)
-14.49%
RETURN ON EQUITY (ROE) AVG TTM
-13.15%
RETURN ON EQUITY (ROE) AVG 3Y
-18.02%
RETURN ON EQUITY (ROE) AVG 5Y
-70.72%
RETURN ON EQUITY (ROE) AVG 10Y
-91.55%
RETURN ON EQUITY (ROE) AVG 15Y
-85.34%
RETURN ON EQUITY (ROE) AVG 20Y
-69.84%
CURRENT VS TTM AVG
-10.22%
CURRENT VS 3Y AVG
+19.57%
CURRENT VS 5Y AVG
+79.51%
CURRENT VS 10Y AVG
+84.17%
CURRENT VS 15Y AVG
+83.02%
CURRENT VS 20Y AVG
+79.25%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+65.51%
vs the sector median at left
Rockwell Medical, Inc.
Market Cap
$30.19M
Return on Equity (ROE)
-14.49%
TTM Avg
-13.15%
3Y Avg
-18.02%
5Y Avg
-70.72%
Market Cap
$30.44M
Return on Equity (ROE)
-15.29%
TTM Avg
-28.05%
3Y Avg
-476.74%
5Y Avg
-371.52%
Market Cap
$29.91M
Return on Equity (ROE)
-116.14%
TTM Avg
-228.74%
3Y Avg
113.10%
5Y Avg
76.03%
Market Cap
$29.74M
Return on Equity (ROE)
-111.81%
TTM Avg
-29.10%
3Y Avg
-257.52%
5Y Avg
159.26%
Market Cap
$30.81M
Return on Equity (ROE)
N/A
TTM Avg
10.32%
3Y Avg
-262.53%
5Y Avg
-267.00%
Market Cap
$29.57M
Return on Equity (ROE)
-120.40%
TTM Avg
-43.89%
3Y Avg
-83.08%
5Y Avg
-65.54%
Market Cap
$30.92M
Return on Equity (ROE)
-132.18%
TTM Avg
-94.77%
3Y Avg
-38.62%
5Y Avg
-46.78%
Market Cap
$29.37M
Return on Equity (ROE)
-117.69%
TTM Avg
-1443.79%
3Y Avg
-971.02%
5Y Avg
-813.57%
Market Cap
$31.11M
Return on Equity (ROE)
-117.97%
TTM Avg
-59.96%
3Y Avg
-42.92%
5Y Avg
-31.82%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rockwell Medical, Inc. (RMTI) | $30.19M | -14.49% | -13.15% | -18.02% | -70.72% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.44M | -15.29% | -28.05% | -476.74% | -371.52% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.91M | -116.14% | -228.74% | 113.10% | 76.03% |
| GridAI Technologies Corp. (GRDX)vs › | $29.74M | -111.81% | -29.10% | -257.52% | 159.26% |
| MDxHealth S.A. (MDXH)vs › | $30.81M | N/A | 10.32% | -262.53% | -267.00% |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | -120.40% | -43.89% | -83.08% | -65.54% |
| CervoMed Inc. (CRVO)vs › | $30.92M | -132.18% | -94.77% | -38.62% | -46.78% |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | -117.69% | -1443.79% | -971.02% | -813.57% |
| Accuray Incorporated (ARAY)vs › | $31.11M | -117.97% | -59.96% | -42.92% | -31.82% |
| Nortech Systems Incorporated (NSYS)vs › | $31.52M | 2.91% | -2.27% | 5.52% | 6.87% |
ROE
-14.5%
ROA
-9.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -14.49% |
| 2026-03-31 | -15.07% |
| 2025-12-31 | -14.37% |
| 2025-09-30 | -14.90% |
| 2025-06-30 | -6.90% |
| 2025-03-31 | -0.84% |
| 2024-12-31 | -1.47% |
| 2024-09-30 | -4.24% |
| 2024-06-30 | -20.31% |
| 2024-03-31 | -40.79% |
| 2023-12-31 | -39.64% |
| 2023-09-30 | -43.17% |
| 2023-06-30 | -121.82% |
| 2023-03-31 | -105.80% |
| 2022-12-31 | -132.43% |
| 2022-09-30 | -156.54% |
| 2022-06-30 | -142.22% |
| 2021-09-30 | -292.01% |
| 2021-06-30 | -176.70% |
| 2021-03-31 | -117.11% |
| 2020-12-31 | -90.40% |
| 2020-09-30 | -70.18% |
| 2020-06-30 | -185.26% |
| 2020-03-31 | -153.55% |
| 2019-12-31 | -167.95% |
| 2019-09-30 | -152.73% |
| 2019-06-30 | -112.59% |
| 2019-03-31 | -174.87% |
| 2018-12-31 | -121.37% |
| 2018-09-30 | -258.64% |
| 2018-06-30 | -194.54% |
| 2018-03-31 | -101.25% |
| 2017-12-31 | -78.76% |
| 2017-09-30 | -53.78% |
| 2017-06-30 | -48.90% |
| 2017-03-31 | -38.97% |
| 2016-12-31 | -37.39% |
| 2016-09-30 | -36.80% |
| 2016-06-30 | -31.88% |
| 2016-03-31 | -25.82% |
| 2015-12-31 | -23.14% |
| 2015-09-30 | -23.33% |
| 2015-06-30 | -25.14% |
| 2015-03-31 | -25.39% |
| 2014-12-31 | -31.04% |
| 2013-09-30 | -887.14% |
| 2013-06-30 | -341.05% |
| 2012-06-30 | -218.73% |
| 2012-03-31 | -113.73% |
| 2011-12-31 | -117.54% |
| 2011-09-30 | -56.71% |
| 2011-06-30 | -35.55% |
| 2011-03-31 | -17.84% |
| 2010-12-31 | -8.79% |
| 2010-09-30 | -5.01% |
| 2010-06-30 | -7.60% |
| 2010-03-31 | -14.01% |
| 2009-12-31 | -18.76% |
| 2009-09-30 | -90.76% |
| 2009-06-30 | -93.85% |
| 2009-03-31 | -78.85% |
| 2008-12-31 | -66.53% |
| 2008-09-30 | -41.76% |
| 2008-06-30 | -23.66% |
| 2008-03-31 | -19.18% |
| 2007-12-31 | -20.71% |
| 2007-09-30 | -59.82% |
| 2007-06-30 | -77.65% |
| 2007-03-31 | -88.47% |
| 2006-12-31 | -54.63% |
| 2006-09-30 | -39.16% |
| 2006-06-30 | -17.47% |
| 2006-03-31 | -2.70% |
| 2005-12-31 | 2.00% |
| 2005-09-30 | 9.02% |
| 2005-06-30 | 7.06% |
| 2005-03-31 | 6.62% |
| 2004-12-31 | 6.18% |
| 2004-09-30 | 8.81% |
| 2004-06-30 | 9.57% |
| 2004-03-31 | 5.25% |
| 2003-12-31 | 0.15% |
| 2003-09-30 | -5.54% |
| 2003-06-30 | -14.93% |
